Harrow, Inc. Investment Income, Interest
Harrow, Inc. (HROW) reported Investment Income, Interest of $32.45 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2015-03-12
- Harrow, Inc. investment income, interest for the quarter ending 2014-12-31 was $5.96K, a 47.33% decline year-over-year.
- Harrow, Inc. investment income, interest for the quarter ending 2014-09-30 was $7.50K, a 39.69% decline year-over-year.
- Harrow, Inc. investment income, interest for the quarter ending 2013-12-31 was $11.31K, a 101.73% increase year-over-year.
- Harrow, Inc. investment income, interest for the quarter ending 2013-09-30 was $12.44K, a 194.72% increase year-over-year.
- Harrow, Inc. investment income, interest for fiscal 2014 was $32.45K, a 25.85% decline from fiscal 2013.
- Harrow, Inc. investment income, interest for fiscal 2013 was $43.76K, a 183.94% increase from fiscal 2012.
- Harrow, Inc. investment income, interest for fiscal 2012 was $15.41K.
- Harrow, Inc. investment income, interest for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 155 month | Investment Income, Interest 158 month | Investment Income, Interest 161 month | Investment Income, Interest 164 month | Investment Income, Interest 167 month | Investment Income, Interest 170 month | Investment Income, Interest 173 month | Investment Income, Interest 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $5.96K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $13.46K derived: sum of 2 quarters · filed 2015-03-12 | $32.45K 10-K · filed 2015-03-12 | |||||||||
| 2014-09-30 | $7.50K 10-Q · filed 2014-11-12 | $26.49K 10-Q · filed 2014-11-12 | ||||||||||
| 2013-12-31 | $11.31K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $23.75K derived: sum of 2 quarters · filed 2015-03-12 | $36.69K derived: sum of 3 quarters · filed 2015-03-12 | $43.76K 10-K · filed 2015-03-12 | ||||||||
| 2013-09-30 | $12.44K 10-Q · filed 2014-11-12 | $25.38K derived: sum of 2 quarters · filed 2014-11-12 | $32.45K 10-Q · filed 2014-11-12 | $38.05K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||
| 2013-06-30 | $12.94K 10-Q · filed 2013-08-14 | $20.01K 10-Q · filed 2013-08-14 | $25.61K derived: sum of 3 quarters · filed 2013-08-14 | $29.83K derived: sum of 4 quarters · filed 2013-08-14 | $163.00K 10-Q · filed 2013-08-14 | |||||||
| 2013-03-31 | $7.07K 10-Q · filed 2013-05-08 | $12.67K derived: sum of 2 quarters · filed 2013-05-08 | $16.89K derived: sum of 3 quarters · filed 2013-05-08 | $22.48K derived: sum of 4 quarters · filed 2013-08-14 | $150.06K 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $5.61K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $9.83K derived: sum of 2 quarters · filed 2013-03-18 | $15.41K derived: sum of 3 quarters · filed 2013-08-14 | $15.41K 10-K · filed 2013-03-18 | $142.99K 10-K · filed 2013-03-18 | |||||||
| 2012-09-30 | $4.22K 10-Q · filed 2012-11-14 | $9.80K derived: sum of 2 quarters · filed 2013-08-14 | $9.80K 10-Q · filed 2012-11-14 | $9.80K derived: sum of 4 quarters · filed 2013-08-14 | $137.39K 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | $5.58K 10-Q · filed 2013-08-14 | $5.58K 10-Q · filed 2013-08-14 | $5.58K derived: sum of 3 quarters · filed 2013-08-14 | $5.58K derived: sum of 4 quarters · filed 2013-08-14 | $133.16K 10-Q · filed 2012-08-14 | |||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $0.00 derived: sum of 4 quarters · filed 2013-05-08 | $127.58K 10-Q · filed 2012-05-10 | |||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | $127.58K 10-K · filed 2012-02-23 | |||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $29.00 derived: sum of 4 quarters · filed 2012-05-10 | $127.58K 10-Q · filed 2012-02-23 | |||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $29.00 derived: sum of 3 quarters · filed 2012-05-10 | $244.00 derived: sum of 4 quarters · filed 2012-05-10 | $127.58K 10-Q · filed 2012-02-23 | |||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $29.00 derived: sum of 2 quarters · filed 2012-05-10 | $244.00 derived: sum of 3 quarters · filed 2012-05-10 | $379.00 derived: sum of 4 quarters · filed 2012-05-10 | ||||||||
| 2010-12-31 | $29.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $244.00 derived: sum of 2 quarters · filed 2012-02-23 | $379.00 derived: sum of 3 quarters · filed 2012-02-23 | $512.00 10-K · filed 2012-02-23 | ||||||||
| 2010-09-30 | $215.00 10-Q · filed 2012-02-23 | $350.00 derived: sum of 2 quarters · filed 2012-02-23 | $483.00 10-Q · filed 2012-02-23 | |||||||||
| 2010-06-30 | $135.00 10-Q · filed 2012-02-23 | $268.00 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |